Pangenomic Health Inc. (CNQ: NARA.CN) Stock Competitors & Peer Comparison
See NARA.CN's competitors and their performance on the CNQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NARA.CN and its CNQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NARA.CN | CA$0.25 | -13.79% | 3.5M | -10.22 | -CA$0.02 | N/A |
| KSI.TO | CA$6.50 | +0.00% | 624.9M | -69.15 | -CA$0.09 | N/A |
| VHI.TO | CA$7.89 | -2.23% | 499.1M | 67.95 | CA$0.12 | N/A |
| CARE.TO | CA$5.15 | +0.10% | 345.7M | -17.15 | -CA$0.30 | N/A |
| AIDR.CN | CA$0.62 | -1.59% | 60.1M | -2.70 | -CA$0.23 | N/A |
| TRUE.CN | CA$0.51 | -1.92% | 38.5M | -2.68 | -CA$0.19 | N/A |
| HS.CN | CA$0.53 | +3.92% | 29M | -3.31 | -CA$0.16 | N/A |
| LYNX.CN | CA$0.20 | +0.00% | 21.4M | -0.95 | -CA$0.21 | N/A |
| AIML.CN | CA$0.05 | +0.00% | 12.7M | -1.04 | -CA$0.05 | N/A |
| RYAH.CN | CA$0.03 | +0.00% | 11.2M | -0.15 | -CA$0.17 | N/A |
Stock Comparison
Kneat.com, Inc. (TSX: KSI.TO)
NARA.CN vs KSI.TO Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, KSI.TO has a market cap of 624.9M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while KSI.TO trades at CA$6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas KSI.TO's P/E ratio is -69.15. In terms of profitability, NARA.CN's ROE is +1.81%, compared to KSI.TO's ROE of -0.13%. Regarding short-term risk, NARA.CN is less volatile compared to KSI.TO. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check KSI.TO's competition here
Vitalhub Corp. (TSX: VHI.TO)
NARA.CN vs VHI.TO Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, VHI.TO has a market cap of 499.1M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while VHI.TO trades at CA$7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas VHI.TO's P/E ratio is 67.95. In terms of profitability, NARA.CN's ROE is +1.81%, compared to VHI.TO's ROE of +0.03%. Regarding short-term risk, NARA.CN is less volatile compared to VHI.TO. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check VHI.TO's competition here
Dialogue Health Technologies Inc. (TSX: CARE.TO)
NARA.CN vs CARE.TO Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, CARE.TO has a market cap of 345.7M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while CARE.TO trades at CA$5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas CARE.TO's P/E ratio is -17.15. In terms of profitability, NARA.CN's ROE is +1.81%, compared to CARE.TO's ROE of -0.23%. Regarding short-term risk, NARA.CN is less volatile compared to CARE.TO. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check CARE.TO's competition here
Rocket Doctor AI Inc. (CNQ: AIDR.CN)
NARA.CN vs AIDR.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, AIDR.CN has a market cap of 60.1M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while AIDR.CN trades at CA$0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas AIDR.CN's P/E ratio is -2.70. In terms of profitability, NARA.CN's ROE is +1.81%, compared to AIDR.CN's ROE of -2.63%. Regarding short-term risk, NARA.CN is less volatile compared to AIDR.CN. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check AIDR.CN's competition here
Treatment.Com International Inc. (CNQ: TRUE.CN)
NARA.CN vs TRUE.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, TRUE.CN has a market cap of 38.5M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while TRUE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas TRUE.CN's P/E ratio is -2.68. In terms of profitability, NARA.CN's ROE is +1.81%, compared to TRUE.CN's ROE of -0.93%. Regarding short-term risk, NARA.CN is less volatile compared to TRUE.CN. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check TRUE.CN's competition here
HS GovTech Solutions Inc. (CNQ: HS.CN)
NARA.CN vs HS.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, HS.CN has a market cap of 29M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while HS.CN trades at CA$0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas HS.CN's P/E ratio is -3.31. In terms of profitability, NARA.CN's ROE is +1.81%, compared to HS.CN's ROE of -1.34%. Regarding short-term risk, NARA.CN is less volatile compared to HS.CN. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check HS.CN's competition here
Lynx Global Digital Finance Corporation (CNQ: LYNX.CN)
NARA.CN vs LYNX.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, LYNX.CN has a market cap of 21.4M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while LYNX.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas LYNX.CN's P/E ratio is -0.95. In terms of profitability, NARA.CN's ROE is +1.81%, compared to LYNX.CN's ROE of -1.35%. Regarding short-term risk, NARA.CN is similarly volatile compared to LYNX.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check LYNX.CN's competition here
AI/ML Innovations Inc. (CNQ: AIML.CN)
NARA.CN vs AIML.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, AIML.CN has a market cap of 12.7M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while AIML.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas AIML.CN's P/E ratio is -1.04. In terms of profitability, NARA.CN's ROE is +1.81%, compared to AIML.CN's ROE of -5.05%. Regarding short-term risk, NARA.CN is similarly volatile compared to AIML.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check AIML.CN's competition here
RYAH Group, Inc. (CNQ: RYAH.CN)
NARA.CN vs RYAH.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, RYAH.CN has a market cap of 11.2M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while RYAH.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas RYAH.CN's P/E ratio is -0.15. In terms of profitability, NARA.CN's ROE is +1.81%, compared to RYAH.CN's ROE of +14.95%. Regarding short-term risk, NARA.CN is similarly volatile compared to RYAH.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check RYAH.CN's competition here
Unidoc Health Corp. (CNQ: UDOC.CN)
NARA.CN vs UDOC.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, UDOC.CN has a market cap of 10.8M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while UDOC.CN trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas UDOC.CN's P/E ratio is -0.75. In terms of profitability, NARA.CN's ROE is +1.81%, compared to UDOC.CN's ROE of +62.39%. Regarding short-term risk, NARA.CN is less volatile compared to UDOC.CN. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check UDOC.CN's competition here
Telecure Technologies Inc. (CNQ: TELE.CN)
NARA.CN vs TELE.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, TELE.CN has a market cap of 7.6M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while TELE.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas TELE.CN's P/E ratio is -0.13. In terms of profitability, NARA.CN's ROE is +1.81%, compared to TELE.CN's ROE of +1.60%. Regarding short-term risk, NARA.CN is similarly volatile compared to TELE.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check TELE.CN's competition here
nDatalyze Corp. (CNQ: NDAT.CN)
NARA.CN vs NDAT.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, NDAT.CN has a market cap of 2.9M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while NDAT.CN trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas NDAT.CN's P/E ratio is -3.52. In terms of profitability, NARA.CN's ROE is +1.81%, compared to NDAT.CN's ROE of -0.50%. Regarding short-term risk, NARA.CN is less volatile compared to NDAT.CN. This indicates lower risk in terms of short-term price fluctuations for NARA.CN.Check NDAT.CN's competition here
SpotLite360 IOT Solutions, Inc. (CNQ: LITE.CN)
NARA.CN vs LITE.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, LITE.CN has a market cap of 2M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while LITE.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas LITE.CN's P/E ratio is -0.21. In terms of profitability, NARA.CN's ROE is +1.81%, compared to LITE.CN's ROE of -6.63%. Regarding short-term risk, NARA.CN is similarly volatile compared to LITE.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check LITE.CN's competition here
Certive Solutions Inc. (CNQ: CBP.CN)
NARA.CN vs CBP.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, CBP.CN has a market cap of 1.7M. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while CBP.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas CBP.CN's P/E ratio is -2.83. In terms of profitability, NARA.CN's ROE is +1.81%, compared to CBP.CN's ROE of +0.17%. Regarding short-term risk, NARA.CN is similarly volatile compared to CBP.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check CBP.CN's competition here
Cognetivity Neurosciences Ltd. (CNQ: CGN.CN)
NARA.CN vs CGN.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, CGN.CN has a market cap of 895.9K. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while CGN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas CGN.CN's P/E ratio is -0.11. In terms of profitability, NARA.CN's ROE is +1.81%, compared to CGN.CN's ROE of +0.96%. Regarding short-term risk, NARA.CN is similarly volatile compared to CGN.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check CGN.CN's competition here
EGF Theramed Health Corp. (CNQ: TMED.CN)
NARA.CN vs TMED.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, TMED.CN has a market cap of 813.2K. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while TMED.CN trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas TMED.CN's P/E ratio is -0.24. In terms of profitability, NARA.CN's ROE is +1.81%, compared to TMED.CN's ROE of +0.80%. Regarding short-term risk, NARA.CN is similarly volatile compared to TMED.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check TMED.CN's competition here
WellteQ Digital Health Inc. (CNQ: WTEQ.CN)
NARA.CN vs WTEQ.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, WTEQ.CN has a market cap of 0. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while WTEQ.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas WTEQ.CN's P/E ratio is 2.00. In terms of profitability, NARA.CN's ROE is +1.81%, compared to WTEQ.CN's ROE of -1.70%. Regarding short-term risk, NARA.CN is not fully comparable compared to WTEQ.CN. This indicates unavailable risk data in terms of short-term price fluctuations for NARA.CN.Check WTEQ.CN's competition here
Nurosene Health Inc. (CNQ: MEND.CN)
NARA.CN vs MEND.CN Comparison August 2026
Pangenomic Health Inc. (CNQ: NARA.CN) plays a significant role within the Healthcare sector. Its performance on the CNQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 3.5M. In comparison, MEND.CN has a market cap of 0. Regarding current trading prices, NARA.CN is priced at CA$0.25 on the CNQ, while MEND.CN trades at CA$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -10.22, whereas MEND.CN's P/E ratio is N/A. In terms of profitability, NARA.CN's ROE is +1.81%, compared to MEND.CN's ROE of -1.68%. Regarding short-term risk, NARA.CN is similarly volatile compared to MEND.CN. This indicates similar risk in terms of short-term price fluctuations for NARA.CN.Check MEND.CN's competition here